Oncology PharmaONPH
13F holders, Q1 2026 (March 31)1holders
1new positions
0sold out
$0.08avg. 13F price*
At the end of Q1 2026, 1 institutions reported holding Oncology Pharma Inc. (ONPH) in their 13F filings, unchanged from Q1 2025. 1 opened new positions and 0 sold out. The largest holder was Ascentis Independent Advisors ($32).
- Company
- Oncology Pharma Inc.
- CUSIP
- 68235J201
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2025 → Q1 2026
| Institutions | Total Value | |
|---|---|---|
| New Positions | 1 | $32 |
| Exits | 0 | $0 |
All 13F filers, Q1 2025 → Q1 2026: 400 shares bought, net +400 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 1 holders
| Ascentis Independent Advisors | 0.00% | New | 400 | $32 |
"% of holder's portfolio" is ONPH's weight in each manager's 13F, not the share of Oncology Pharma Inc. the manager owns.